Map Pharmaceuticals planning follow-on

Map Pharmaceuticals Inc. (NASDAQ:MAPP) said late Tuesday it is planning a follow-on underwritten by BofA Merrill Lynch. Map was off $0.17 to $14.11 on the day. ...